Figure S7 from RAS(ON) Multiselective Inhibition Drives Antitumor Immunity in Preclinical Models of NRAS-Mutant Melanoma

Read full text
Authors: Larissa Anastácio da Costa Carvalho, Nataliya Tovbis Shifrin, Manali S. Phadke, Michael F. Emmons, Ximo Pechuan-Jorge, Felix Mbuga, Oscar E. Ospina, Christopher Chow, Lillian Seu, Olivia L. Rose, Aparna Madhukeshwar Hegde, Nikhil I. Khushalani
+2 more Elsa Quintana, Keiran S.M. Smalley
Cited by: 0

Abstract

Supplemental Figure 7: The RMC-7977 + anti-PD1 combination reprograms the tumor microenvironment to a more pro-inflammatory state. (A) UMAP plot showing the distribution of myeloid cells. (B) Cluster frequency distribution of myeloid cells in the control (vehicle + IgG), Anti-PD1, RMC-7977 and RMC-7977 + Anti-PD1 groups. (C) UMAP plot showing the distribution of myeloid cells subtypes. (D) Cluster frequency distribution of myeloid cell subtypes in the control (vehicle + IgG), Anti-PD1, RMC-7977 and RMC-7977 + Anti-PD1 groups. R1, R2 and R3: replicates.

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Immune cells in cancer Immunotherapy and Immune Responses

Publication details

Publication date
8 January 2026